Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Alleviant ALLAY-HFrEF Study [NA]

View source ↗

Summary

Alleviant Medical's ALLAY-HFrEF trial is currently enrolling by invitation for heart failure, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLAY-HFrEF

Snippet

Sponsor: Alleviant Medical, Inc. | Conditions: Heart Failure | NA | Status: ENROLLING_BY_INVITATION